Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPECT ESUS
2013-003444-24Phase 3Completed
- Sponsor
- Unilfarma
- Start
- Sep 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stroke and embolic stroke of undetermined source (ESUS) comparing dabigatran etexilate with acetylsalicylic acid (2 arms). Primary endpoint: Time to first recurrent stroke. Started Sep 2014; status: completed.
02
Drugs
dabigatranaspirin
03
Conditions
strokeembolic stroke of undetermined source (ESUS)
Beyond the preview
Go deeper on 2013-003444-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003444-24.